Postavení preparátu ZD 1839 (IRESSA) v léčbě nemocných s pokročilým nemalobuněčným karcinomem (NSCLC)

• Title in English: ZD 1839 (IRESSA) in treatment of patients with advanced non-small cell lung cancer (NSCLC)
• Authors: SKŘIČKOVÁ Jana; TOMÍŠKOVÁ Marcela; BABIČKOVÁ Lenka; KAPLANOVÁ Jana; PÁLKOVÁ Ivana; SVOBODNÍK Adam
• Year of publication: 2004
• Type: Article in Proceedings
• Conference: XVIII. brněnské onkologieké dny a XVIII. konference pro sestry a laboranty - edukační sborník
• MU Faculty or unit: Faculty of Medicine
• Field: Pneumology
• Keywords: gefitinib; IRESSA; treatment od non-small cell lung cancer; biological treatment of lung cancer
• Description: Biological or targeted therapy of non-small cell lung cancer is a recent promising treatment option for pacients where standard anti-cancer drug therapy fails. The authors present their own experience with 58 patients treated in 2004-2004.

Related projects

• Environment - carcinogenesis - oncology